News Medical on MSN5 小时
Medtronic receives FDA approval for BrainSense Adaptive DBS technology
For the one million people diagnosed with Parkinson's disease in the United States, Medtronic plc (NYSE:MDT), a global leader in healthcare technology, proudly announces U.S. Food and Drug ...
Le Lézard9 分钟
Endologix Appoints Andrew Davis as Chief Commercial Officer
Endologix LLC, a privately held global medical device company specializing in innovative therapies for vascular disease, is pleased to announce the appointment of Andrew Davis as its new Chief ...
来自MSN15 小时
FDA Takes Action on Allergies, Diabetes, Parkinson’s, and Deadly Food Safety Scare—What ...
The U.S. Food and Drug Administration (FDA) has announced several significant developments this week, spanning advancements ...
来自MSN5 小时
Twice-Yearly Biologic Effective Against Nasal Polyps
Novel ultra-long-acting biologic depemokimab reduced nasal polyps in chronic rhinosinusitis, two parallel phase III trials ...